FI892114A - Foerfarande foer framstaellning av polypeptider. - Google Patents

Foerfarande foer framstaellning av polypeptider. Download PDF

Info

Publication number
FI892114A
FI892114A FI892114A FI892114A FI892114A FI 892114 A FI892114 A FI 892114A FI 892114 A FI892114 A FI 892114A FI 892114 A FI892114 A FI 892114A FI 892114 A FI892114 A FI 892114A
Authority
FI
Finland
Prior art keywords
polypeptiders
framing procedure
frequency framing
production
frequency
Prior art date
Application number
FI892114A
Other languages
English (en)
Other versions
FI103129B1 (fi
FI103129B (fi
FI892114A0 (fi
Inventor
Hansjoerg Treichler
Kenji Takabayashi
Dieter Heinrich Wolf
Jutta Heim
Original Assignee
Ciba Geigy Ag
Ucp Gen Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888810524A external-priority patent/GB8810524D0/en
Priority claimed from GB888812627A external-priority patent/GB8812627D0/en
Priority claimed from GB898907110A external-priority patent/GB8907110D0/en
Application filed by Ciba Geigy Ag, Ucp Gen Pharma Ag filed Critical Ciba Geigy Ag
Publication of FI892114A0 publication Critical patent/FI892114A0/fi
Publication of FI892114A publication Critical patent/FI892114A/fi
Application granted granted Critical
Publication of FI103129B1 publication Critical patent/FI103129B1/fi
Publication of FI103129B publication Critical patent/FI103129B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
FI892114A 1988-05-04 1989-05-03 Saccaharomyces cerevisiae -kanta ja menetelmä S. cerevisiaelle heterol ogisen proteiinin tuottamiseksi FI103129B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8810524 1988-05-04
GB888810524A GB8810524D0 (en) 1988-05-04 1988-05-04 Improvements in production of polypeptides
GB888812627A GB8812627D0 (en) 1988-05-27 1988-05-27 Improvements in production of polypeptides
GB8812627 1988-05-27
GB8907110 1989-03-29
GB898907110A GB8907110D0 (en) 1988-05-04 1989-03-29 Improvements in the production of polypeptides

Publications (4)

Publication Number Publication Date
FI892114A0 FI892114A0 (fi) 1989-05-03
FI892114A true FI892114A (fi) 1989-11-05
FI103129B1 FI103129B1 (fi) 1999-04-30
FI103129B FI103129B (fi) 1999-04-30

Family

ID=27263890

Family Applications (1)

Application Number Title Priority Date Filing Date
FI892114A FI103129B (fi) 1988-05-04 1989-05-03 Saccaharomyces cerevisiae -kanta ja menetelmä S. cerevisiaelle heterol ogisen proteiinin tuottamiseksi

Country Status (16)

Country Link
EP (1) EP0341215B1 (fi)
JP (1) JPH0824565B2 (fi)
AT (1) ATE124086T1 (fi)
AU (1) AU614121B2 (fi)
CA (1) CA1340016C (fi)
DE (1) DE68923123T2 (fi)
DK (1) DK175701B1 (fi)
ES (1) ES2072918T3 (fi)
FI (1) FI103129B (fi)
HU (1) HU218731B (fi)
IE (1) IE66044B1 (fi)
IL (1) IL90170A (fi)
MX (1) MX169508B (fi)
NO (1) NO180593C (fi)
NZ (1) NZ228955A (fi)
PT (1) PT90436B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8809860D0 (en) * 1988-04-26 1988-06-02 Ciba Geigy Ag Process for production of polypeptides
US5879926A (en) * 1989-03-31 1999-03-09 Transgene S.A. Yeast strains for the production of mature heterologous proteins, especially hirudin
FR2645175B1 (fr) * 1989-03-31 1994-02-18 Transgene Sa Souche de saccharomyces cerevisiaeproductrice d'une proteine heterologue et procede de preparation de ladite proteine heterologue par fermentation de ladite souche
FR2645174B1 (fr) * 1989-03-31 1994-01-07 Transgene Sa Souches de levure ameliorees pour la production de proteines heterologues matures en particulier d'hirudine et procede de preparation d'hirudine correspondant
EP0502962B1 (de) * 1989-12-01 1996-03-13 BASF Aktiengesellschaft Hirudin-Muteine und deren Polyalkylenglykolkonjugate
ES2080957T3 (es) * 1990-07-13 1996-02-16 Transkaryotic Therapies Inc Metodo para escrutar una genoteca.
US5580734A (en) * 1990-07-13 1996-12-03 Transkaryotic Therapies, Inc. Method of producing a physical map contigous DNA sequences
US5612198A (en) * 1990-09-04 1997-03-18 The Salk Institute Production of insulin-like growth factor-1 in methylotrophic yeast cells
JPH06500470A (ja) * 1990-09-04 1994-01-20 メルク　エンド　カンパニー　インコーポレーテッド メチロトローフ酵母細胞におけるインスリン様成長因子の産生
WO1992008736A1 (fr) 1990-11-08 1992-05-29 Nippon Mining Company Limited Mutant d'hirudine, sa production, anticoagulant, vecteur secretoire, microorganisme transforme par ledit vecteur et production d'un produit a partir dudit microorganisme
SG84484A1 (en) * 1991-02-25 2001-11-20 Ciba Geigy Ag Improved yeast vectors
ES2177528T3 (es) * 1991-04-01 2002-12-16 Merck & Co Inc Genes que influyen en la actividad proteolitica de pichia y usoso de los mismos.
HU214698B (hu) * 1992-04-09 1998-06-29 Gyógyszerkutató Intézet Kft. Eljárás rekombináns deszulfátó-hirudin HV-1 peptidek előállítására
EP1031628A1 (en) * 1992-09-04 2000-08-30 Novartis AG Process for the production of protease inhibitors
TW282490B (fi) * 1992-12-15 1996-08-01 Ciba Geigy Ag
CA2144523A1 (en) * 1993-08-04 1995-02-16 Hugo Grossenbacher High molecular weight desulphatohirudin
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
WO1996024678A1 (en) * 1995-02-09 1996-08-15 Novartis Ag Process for the production of proteins
CN1769423A (zh) * 1995-03-20 2006-05-10 诺沃奇梅兹有限公司 表达降低水平的金属蛋白酶的宿主细胞和在蛋白质产生中使用该宿主细胞的方法
DE19529997C1 (de) 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
AU7112796A (en) * 1995-09-27 1997-04-17 Chiron Corporation Method of making a protease deficient host
DE69625623T2 (de) 1996-01-31 2003-11-06 Sumitomo Bakelite Co. Ltd., Tokio/Tokyo Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
FR2768743B1 (fr) * 1997-09-23 2001-09-14 Bio Merieux Procede de lyse de micro-organisme
GB2338236B (en) 1998-06-13 2003-04-09 Aea Technology Plc Microbiological cell processing
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
US8815541B2 (en) 2009-11-25 2014-08-26 Novo Nordisk A/S Method for making polypeptides
AU2018348518B2 (en) 2017-10-10 2024-05-16 Ajinomoto Co., Inc. Method for manufacturing protein
JPWO2021251383A1 (fi) 2020-06-11 2021-12-16

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
JPS62224284A (ja) * 1986-03-25 1987-10-02 Agency Of Ind Science & Technol 微生物
GB8809860D0 (en) * 1988-04-26 1988-06-02 Ciba Geigy Ag Process for production of polypeptides
GB8817161D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Modified proteins
GB8817160D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Novel proteins

Also Published As

Publication number Publication date
ES2072918T3 (es) 1995-08-01
NO180593B (no) 1997-02-03
EP0341215A2 (en) 1989-11-08
EP0341215B1 (en) 1995-06-21
NO891837D0 (no) 1989-05-03
IE66044B1 (en) 1995-12-13
FI103129B1 (fi) 1999-04-30
IL90170A0 (en) 1989-12-15
NO180593C (no) 1997-05-14
DK217589D0 (da) 1989-05-03
DK217589A (da) 1989-11-05
PT90436A (pt) 1989-11-30
HU218731B (hu) 2000-11-28
DK175701B1 (da) 2005-01-24
PT90436B (pt) 1994-11-30
AU614121B2 (en) 1991-08-22
CA1340016C (en) 1998-08-25
AU3382889A (en) 1989-11-09
NZ228955A (en) 1991-06-25
DE68923123D1 (de) 1995-07-27
EP0341215A3 (en) 1992-01-15
DE68923123T2 (de) 1995-11-30
FI103129B (fi) 1999-04-30
IE891451L (en) 1989-11-04
NO891837L (no) 1989-11-06
IL90170A (en) 1995-12-31
JPH02104279A (ja) 1990-04-17
ATE124086T1 (de) 1995-07-15
JPH0824565B2 (ja) 1996-03-13
HUT54210A (en) 1991-01-28
FI892114A0 (fi) 1989-05-03
MX169508B (es) 1993-07-08

Similar Documents

Publication Publication Date Title
FI892114A (fi) Foerfarande foer framstaellning av polypeptider.
AU3120689A (en) CKS method of protein synthesis
FI931634A0 (fi) Nytt svampproteas
EP0307472A4 (en) IMMUNOGENIC PRODUCT OBTAINED BY EXPRESSION FROM RECOMBINANT YEAST AND PROCESS FOR PURIFYING SUCH A PRODUCT.
DE69028890D1 (de) Ergiebige Herstellung von Protease-Mutanten
AU591305B2 (en) Improved process for preparing 5,6-substitued-2,4- quinazolinediamines and novel intermediates
PT88436A (pt) Process for the preparation of modified plasminogen activators
DE69329540D1 (de) Verfahren zur Herstellung von Proteaseinhibitoren
EP0277585A3 (en) Fiber forming bushing
EP0276008A3 (en) Fibrin-specific antibody, method for its production and its use
GR900100615A (el) Νεοι υποκατεστημενοι ετεροκυκλικοι δακτυλιοι πεντανιου,παραγωγη και χρησις αυτων.
FI873489A (fi) Foerfarande foer framstaellning av 4-androsten-3,17-dion och 1,4-androstadien-3,17-dion.
GR3007115T3 (fi)
RO88419A (ro) Procedeu pentru prepararea unor n-arilhalopirolidone
NO881812L (no) Fremgangsmaate for fremstilling av krystallinsk n-(s-3-metyl-heptanoyl)-d-gamma-glutamyl-glycyl-d-alanin og mellomprodukter for fremstillingen.
HUT50145A (en) Process for production of substituated 1,2,3-tiadiasole 4-tiasole

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FG Patent granted

Owner name: UCP GEN-PHARMA AG

Owner name: NOVARTIS AG

MA Patent expired